成人急性髓系白血病中复发性遗传异常的频率及预后影响的性别差异(Alliance,AMLCG)
研究对1726例接受Alliance前线方案的成人AML患者(女749例,男977例)进行突变谱、细胞遗传学和结局分析,并以德国AML协作组465例女性和489例男性作为验证队列。女性更常见正常核型、FLT3-ITD、DNMT3A、NPM1和WT1突变,男性更常见复杂核型、ASXL1、SRSF2、U2AF1、RUNX1或KIT突变。在<60岁患者中,SF3B1突变是男性特有的不良结局预后因素。
要点
- 女性AML更常见正常核型及FLT3-ITD、DNMT3A、NPM1、WT1突变。
- 男性AML更常见复杂核型及ASXL1、SRSF2、U2AF1、RUNX1、KIT突变。
- 在<60岁患者中,SF3B1突变是男性特有的不良结局预后因素。
核心结论
- AML相关遗传 alteration 的性别差异及突变特异性差异剪接事件凸显了患者性别在AML生物学和预后分析中的重要性。
研究设计与样本
- 在1726例成人AML患者(女749例,男977例)中开展突变谱、细胞遗传学和结局分析,患者接受Alliance for Clinical Trials in Oncology前线方案治疗。
- 验证队列包括德国AML协作组前线方案治疗的465例女性和489例男性。
主要发现
- 与男性相比,女性更常见正常核型、FLT3-ITD、DNMT3A、NPM1和WT1突变,较少见复杂核型、ASXL1、SRSF2、U2AF1、RUNX1或KIT突变。
- 更多女性属于2022年欧洲白血病网(ELN)中危组,更多男性属于不良风险组。
- 发现共存突变模式和特定遗传 alteration 的预后影响存在性别差异。
- 突变相关的剪接事件和基因表达谱在性别间也存在差异。
- 在<60岁患者中,SF3B1突变是男性特有的不良结局预后因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical outcome of patients with acute myeloid leukemia (AML) is associated with demographic and genetic features. Although the associations of acquired genetic alterations with patients' sex have been recently analyzed, their impact on outcome of female and male patients has not yet been comprehensively assessed. We performed mutational profiling, cytogenetic and outcome analyses in 1726 adults with AML (749 female and 977 male) treated on frontline Alliance for Clinical Trials in Oncology protocols. A validation cohort comprised 465 women and 489 men treated on frontline protocols of the German AML Cooperative Group. Compared with men, women more often had normal karyotype, FLT3-ITD, DNMT3A, NPM1 and WT1 mutations and less often complex karyotype, ASXL1, SRSF2, U2AF1, RUNX1, or KIT mutations. More women were in the 2022 European LeukemiaNet intermediate-risk group and more men in adverse-risk group. We found sex differences in co-occurring mutation patterns and prognostic impact of select genetic alterations. The mutation-associated splicing events and gene-expression profiles also differed between sexes. In patients aged <60 years, SF3B1 mutations were male-specific adverse outcome prognosticators. We conclude that sex differences in AML-associated genetic alterations and mutation-specific differential splicing events highlight the importance of patients' sex in analyses of AML biology and prognostication.
引用
- Ozga M, Nicolet D, Mrózek K, et al. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia. 2023. PMID: 38017103. doi:10.1038/s41375-023-02068-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。